Qiagen N.V. (QGEN) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Qiagen N.V. (QGEN) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (65/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+222.9% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How QGEN Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | 62.2% | 22.3% | $424.9M | $453.3M | 8% |
| FY 2024 | $1.98B | 48.9% | 4.9% | $83.6M | $506.4M | 2.1% |
| FY 2023 | $1.97B | 44% | 20.9% | $341.3M | $371.0M | 9.4% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring QGEN)
- ✓Live walkthrough of QGEN's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
QGEN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +5.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on QGEN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for QGEN. Explore sector supply chains on /butterfly.
QGEN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Qiagen N.V. (QGEN)?
In FY 2025 (10-K), QGEN converted $2.1B of revenue into a 62.2% gross margin, 22.3% operating margin, and $453.3M in free cash flow (21.7% FCF margin).